These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38884317)

  • 1. JN.1 and the ongoing battle: unpacking the characteristics of a new dominant COVID-19 variant.
    Eshraghi R; Bahrami A; Karimi Houyeh M; Nasr Azadani M
    Pathog Glob Health; 2024 Jun; ():1-6. PubMed ID: 38884317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.
    Moustsen-Helms IR; Bager P; Larsen TG; Møller FT; Vestergaard LS; Rasmussen M; Hansen CH;
    Lancet Infect Dis; 2024 May; ():. PubMed ID: 38761806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion.
    Li P; Liu Y; Faraone JN; Hsu CC; Chamblee M; Zheng Y-M; Carlin C; Bednash JS; Horowitz JC; Mallampalli RK; Saif LJ; Oltz EM; Jones D; Li J; Gumina RJ; Liu S-L
    mBio; 2024 May; 15(5):e0075124. PubMed ID: 38591890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring New COVID-19 Incertitude: JN.1 Variant- JN.1: The Queer Bird Among Omicron Sublineages.
    Ray SK; Mukherjee S
    Infect Disord Drug Targets; 2024 Jun; ():. PubMed ID: 38939989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad immunogenicity to prior SARS-CoV-2 strains and JN.1 variant elicited by XBB.1.5 vaccination in nursing home residents.
    Abul Y; Nugent C; Vishnepolskiy I; Wallace T; Dickerson E; Holland L; Esparza I; Winkis M; Wali KT; Chan PA; Baier RR; Recker A; Kaczynski M; Kamojjala S; Pralea A; Rice H; Osias O; Oyebanji OA; Olagunju O; Cao Y; Li CJ; Roederer A; Pfeifer WM; King CL; Bosch J; Nanda A; McNicoll L; Mujahid N; Raza S; Tyagi R; Wilson BM; White EM; Canaday DH; Gravenstein S; Balazs AB
    medRxiv; 2024 Mar; ():. PubMed ID: 38585784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appearance and Prevalence of JN.1 SARS-CoV-2 Variant in India and Its Clinical Profile in the State of Maharashtra.
    Karyakarte RP; Das R; Rajmane MV; Dudhate S; Agarasen J; Pillai P; Chandankhede PM; Labhshetwar RS; Gadiyal Y; Kulkarni PP; Nizarudeen S; Yanamandra S; Taji N; Joshi S; Potdar V
    Cureus; 2024 Mar; 16(3):e56718. PubMed ID: 38646375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Navigating Novel Uncertainties of COVID-19: The Rise of the JN.1 Variant.
    Altamimi I; Alabdulkarim IM; Alhumimidi AS; Albabtain MA; Temsah MH
    Cureus; 2024 Jan; 16(1):e51497. PubMed ID: 38304689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving immune evasion and transmissibility of SARS-CoV-2: The emergence of JN.1 variant and its global impact.
    Ou G; Yang Y; Zhang S; Niu S; Cai Q; Liu Y; Lu H
    Drug Discov Ther; 2024 Mar; 18(1):67-70. PubMed ID: 38382991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1.
    Sohail MS; Ahmed SF; Quadeer AA; McKay MR
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion.
    Li P; Liu Y; Faraone J; Hsu CC; Chamblee M; Zheng YM; Carlin C; Bednash JS; Horowitz JC; Mallampalli RK; Saif LJ; Oltz EM; Jones D; Li J; Gumina RJ; Liu SL
    bioRxiv; 2024 Mar; ():. PubMed ID: 38559216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging challenge of FLiRT variants: KP.1.1 and KP.2 in the global pandemic landscape.
    Kumar P; Jayan J; Sharma RK; Gaidhane AM; Syed Zahiruddin Q; Rustagi S; Satapathy P
    QJM; 2024 Jun; ():. PubMed ID: 38867702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of SARS-CoV-2 Omicron Variant JN.1 in Tamil Nadu, India - Clinical Characteristics and Novel Mutations.
    Selvavinayagam ST; Sankar S; Yong YK; Murugesan A; Suvaithenamudhan S; Hemashree K; Rajeshkumar M; Kumaresan A; Pandey RP; Shanmugam S; Arthydevi P; Kumar MS; Gopalan N; Kannan M; Cheedarla N; Tan HY; Zhang Y; Larsson M; Balakrishnan P; Velu V; Byrareddy SN; Shankar EM; Raju S
    medRxiv; 2024 Apr; ():. PubMed ID: 38699322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection of the emerging SARS-CoV-2 BA.2.86 lineage through integrated genomic surveillance of wastewater and COVID-19 cases in Sweden, weeks 31 to 38 2023.
    Espinosa-Gongora C; Berg C; Rehn M; Varg JE; Dillner L; Latorre-Margalef N; Székely AJ; Andersson E; Movert E
    Euro Surveill; 2023 Nov; 28(46):. PubMed ID: 37971659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron variants of SARS-CoV-2: Epidemiological and clinical insights from a tertiary care center in Saudi Arabia.
    Dubaie B; Aldayel A; Alwethinani S; Alhuthil R; Alhamlan F; Alghamdi S; Alsuhaibani M; Aljumaah S; AlYabes O; AlBanyan E; Al-Hajjar S
    J Infect Public Health; 2024 Jun; 17(6):961-966. PubMed ID: 38608457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies.
    He Q; An Y; Zhou X; Xie H; Tao L; Li D; Zheng A; Li L; Xu Z; Yu S; Wang R; Hu H; Liu K; Wang Q; Dai L; Xu K; Gao GF
    Med; 2024 May; 5(5):401-413.e4. PubMed ID: 38574739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timely Monitoring of SARS-CoV-2 RNA Fragments in Wastewater Shows the Emergence of JN.1 (BA.2.86.1.1, Clade 23I) in Berlin, Germany.
    Bartel A; Grau JH; Bitzegeio J; Werber D; Linzner N; Schumacher V; Garske S; Liere K; Hackenbeck T; Rupp SI; Sagebiel D; Böckelmann U; Meixner M
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omicron variant evolution on vaccines and monoclonal antibodies.
    Sabbatucci M; Vitiello A; Clemente S; Zovi A; Boccellino M; Ferrara F; Cimmino C; Langella R; Ponzo A; Stefanelli P; Rezza G
    Inflammopharmacology; 2023 Aug; 31(4):1779-1788. PubMed ID: 37204696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-incidence of BA.1 and BA.2 at the start of Singapore's Omicron wave revealed by Community and University Campus wastewater surveillance.
    Chua FJD; Kim SY; Hill E; Cai JW; Lee WL; Gu X; Afri Affandi SA; Kwok WCG; Ng W; Leifels M; Armas F; Chandra F; Chen H; Alm EJ; Tay M; Wong CCJ; Ng LC; Wuertz S; Thompson JR
    Sci Total Environ; 2023 Jun; 875():162611. PubMed ID: 36871716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.